FeesSafety
Pluang+

Investing $100K in QQQ at 40 could grow to $1M by 52 if past decade's 22% returns repeat.

Market News
17 Sep 2026
24/7 Wall Street
View Source
Neutral
Investing $100K in QQQ at 40 could grow to $1M by 52 if past decade's 22% returns repeat.

If the Invesco QQQ Trust ETF repeats its past decade's annualized return of about 22%, a $100,000 investment made at age 40 could grow to $1 million by age 52. However, QQQ's longer-term since-inception return is closer to 11%, which would extend the timeline to age 63, and a more conservative 8% return pushes it to age 70. The ETF is heavily concentrated in tech and semiconductor stocks, making it vulnerable to sector-specific risks and market cycles. Investors should plan for average returns around 11% and continue contributing regularly rather than relying on an exceptional decade repeating.

The story about the Invesco QQQ Trust ETF's potential returns provides context for readers interested in technology stocks. For readers following the technology sector, here is Pluang's market snapshot as of Sep 18, 2026 02:02 WIB: out of 150 priced Technology-sector US stocks tradable on Pluang, 117 rose and 33 fell today. Notable movers include RKLB (Rocket Lab USA Inc) at USD 67.92 with a 1-day change of +6.62% and Pluang order activity of 91% Sell / 9% Buy, RIOT (Riot Platforms Inc) at USD 21.67 with +6.49% change and 100% Sell activity, and SWKS (Skyworks Solutions Inc) at USD 91.08 with +6.41% change and 88% Sell / 12% Buy activity.

More News

BDR sues FDA over exclusivity of Phathom's VOQUEZNA, challenging patent extension under GAIN Act.

BDR sues FDA over exclusivity of Phathom's VOQUEZNA, challenging patent extension under GAIN Act.

BDR Pharmaceuticals has filed a lawsuit against the FDA, disputing the agency's refusal to accept an abbreviated new drug application referencing Phathom Pharmaceuticals' VOQUEZNA. BDR claims the FDA wrongly extended Phathom's exclusivity period unde...

Market News
Bearish
49 minutes ago
Ipsos reports 2.0% organic growth in Q3, upgrades 2026 growth outlook amid AI and digital expansion.

Ipsos reports 2.0% organic growth in Q3, upgrades 2026 growth outlook amid AI and digital expansion.

Ipsos achieved 2.0% organic revenue growth in Q3 2026, up from 0.8% in H1, driven by strong performances in EMEA, China, and citizen-related activities. The company updated its 2026 organic growth target to 1.2%-1.5%, reflecting improved momentum and...

Company Fundamentals
Bullish
3 hours ago
Ipsos reports 2.0% organic growth in Q3 2026, driven by EMEA, China, and Citizens segment.

Ipsos reports 2.0% organic growth in Q3 2026, driven by EMEA, China, and Citizens segment.

Ipsos posted €636.2 million revenue in Q3 2026 with 2.0% organic growth, up from 0.8% in H1, led by strong performances in EMEA, China, and its Citizens business. The company updated its full-year organic growth outlook to 1.2%-1.5%, citing ongoing g...

Company Fundamentals
Bullish
3 hours ago
Signify posts Q3 profit growth despite sales dip, confirms full-year margin outlook

Signify posts Q3 profit growth despite sales dip, confirms full-year margin outlook

Signify reported third-quarter 2026 results with sales of EUR 1,367 million, a slight decline in comparable sales by 3.4%, but improved adjusted EBITA of EUR 145 million and a margin increase to 10.6%. Net income rose to EUR 88 million and free cash ...

Company Fundamentals
Bullish
3 hours ago
New token Project Kimchi peaks at $15M then crashes 98% amid rug pull suspicions

New token Project Kimchi peaks at $15M then crashes 98% amid rug pull suspicions

A new token called Project Kimchi, promoted by popular trader Kimchi and Pump.fun co-founder Alon, surged to a $15 million market cap within minutes before crashing over 98%. The promotional post was quickly deleted, sparking accusations of a rug pul...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App